In Vivo presents another installment of our quarterly review of dealmaking--in this case July 2001-September 2001. Our data come from Windhover's Strategic Transactions Database. We include medical device financings by deal type; diagnostic financings by industry segment; pharma and biotech alliances by therapeutic category and industry segment; pharma and biotech financings by market segment, and pharma and biotech M&A.
In this issue we are presenting our quarterly review of dealmaking for July-September 2001. Our data comes from Windhover's Strategic Transactions Database, which covers the deal activity within the pharmaceutical/biotechnology, medical device, and in vitrodiagnostics industries.
Some notes about our coverage: we limit our review to deals involving human health care (thus no animal health or...